Itron (NASDAQ: ITRI) insider files to sell 4,486 shares after vesting
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
Itron insider files Form 144 to sell common stock. Christopher E. Ware reported proposed sales of 4,486 common shares tied to restricted stock vesting dated 02/18/2026. The filing also shows 343 shares sold during the prior three months on 11/24/2025.
Positive
- None.
Negative
- None.
Insights
Routine insider sale notice; volume is small relative to a typical market float.
The Form 144 lists a proposed sale of 4,486 common shares associated with restricted stock vesting on 02/18/2026. This indicates a planned disposition by the reporting person following vesting rather than an open-market acquisition.
Past activity shows 343 shares sold on 11/24/2025. Timing, pricing, and exact proceeds are not provided in the excerpt; subsequent trade reports will show execution details.
FAQ
What does Christopher E. Ware's Form 144 for ITRI report?
The filing reports a proposed sale of 4,486 common shares tied to restricted stock vesting on 02/18/2026. It also notes 343 shares sold on 11/24/2025.
Why is restricted stock vesting mentioned in the ITRI Form 144?
The Form 144 links the proposed sale of 4,486 shares to restricted stock vesting dated 02/18/2026, indicating the shares became eligible for sale upon vesting.
Who is the broker or intermediary listed on the Form 144 for ITRI?
The filing lists Fidelity Brokerage Services LLC with an address at 900 Salem Street, Smithfield, RI 02917 as the broker associated with the transaction information.
What dates are relevant in the ITRI Form 144 excerpt?
Key dates shown are the restricted stock vesting date and proposed sale activity on 02/18/2026, the filing reference date 02/19/2026, and a prior sale on 11/24/2025.